Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
October 27, 2026

Regeneron agrees to $270m extension to supply Ebola medicine in US

Regeneron Pharmaceuticals has agreed to a nearly $270m contract extension to supply its Ebola therapy, Inmazeb, to the US Government through 2031.

Continue
Regeneron will supply extra doses of the three-antibody formulation to maintain national emergency stockpiles. Credit: lev radin / Shutterstock.com.
October 27, 2026

China’s NMPA accepts Innovent application for sintilimab combo

The regulatory filing relies on findings from MIZAR-003, a Phase II trial assessing GC101 with sintilimab against chemotherapy. Credit: Asian Isolated / Shutterstock.com.
October 26, 2026

Lunit and Summit to evaluate pathology platform for tumour analysis

The companies plan to utilise Lunit SCOPE IO to identify biomarkers, stratify patients, and investigate biological responses to ivonescimab. Credit: Gorodenkoff / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Pathos AI completes $237m Series E round to expand oncology pipeline
  2. Boehringer and Microsoft collaborate to explore AI in clinical research
  3. Celltrion and Kaigene sign $580m licence deal for KG013
  4. Astellas and AI Proteins sign miniprotein therapeutics deal
  5. MSD’s Keytruda and Padcev combination receives EC approval

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography